Recall

Losartan Recalled Expanded: Ten Lots Recalled

On January 3, 2019, the FDA issued yet another recall of Losartan Potassium tablets. The first recall was issued November 9, 2018, and involved 2 lots. Now, Torrent Pharmaceuticals Limited is recalling a total of 10 lots due to the unexpected impurity N-nitrosodiethylamine (NDEA) found in the drug.

Losartan is a medication used to treat hypertension. It was recalled following the recall of similar drugs Valsartan and Irbesartan for containing NDEA and N-nitrosodimethylamine (NDMA). These substances are classified as probable human carcinogens by the Environmental Protection Agency. Exposure to NDEA can cause:

  • Liver Cancer
  • Stomach Cancer
  • Colon Cancer
  • Intestinal Cancer
  • Prostate Cancer (Must be diagnosed before age 60)
  • Lower Esophageal Cancer
  • Non-Hodgkin Lymphoma
  • Multiple Myeloma
  • Leukemia
  • Pancreatic Cancer

The products subject to recall can be found on the FDA’s website, which lists the product description, batch/lot number, and expiration date.

If you or a loved one was diagnosed with liver cancer, stomach cancer, colorectal cancer, intestinal cancer, esophageal cancer, prostate cancer, pancreatic cancer, non-Hodgkin's lymphoma, leukemia, or multiple myeloma after taking Losartan, please contact us. We have over 30 years of experience handling dangerous drug cases. At GoldenbergLaw, we deliver the Gold standard advocacy you deserve.

Losartan Recalled: List of Recalled Sartan Drugs Continues to Grow

On November 9, 2018, the FDA issued a recall of Losartan due to carcinogen contamination concerns. Losartan is now the third “sartan” drug that has been recalled after the carcinogen N-Nitrosodiethylamine (NDEA) was detected in its active pharmaceutical ingredient.

The recalled lots of Losartan were manufactured by Zhejiang Huahai Pharmaceutical Co. Ltd., the same company that manufactured the NDMA-contaminated Valsartan. Since then, the FDA has put Zhejiang Huahai Pharmaceutical on an import alert, meaning the FDA “has enough evidence to allow for Detention Without Physical Examination of products that appear to be in violation of FDA laws and regulations.”

NDEA is a probable human carcinogen and can cause:

  • Liver Cancer
  • Stomach Cancer
  • Colon Cancer
  • Intestinal Cancer
  • Prostate Cancer (Must be diagnosed before age 60)
  • Lower Esophageal Cancer
  • Non-Hodgkin Lymphoma
  • Multiple Myeloma
  • Leukemia
  • Pancreatic Cancer

If you or a loved one contracted liver cancer, stomach cancer, colorectal cancer, intestinal cancer, esophageal cancer, prostate cancer, pancreatic cancer, non-Hodgkin's lymphoma, leukemia, or multiple myeloma after taking Losartan, contact GoldenbergLaw. Leave the sleepless nights to us.

Categories

We Truly Care

The GoldenbergLaw Difference
  • Kindness Is Strength.

    With us, you matter most. This team spends the time to ensure clients like you get to rest and leave the sleepless nights to us.

  • Accountability Is Bravery.

    We live and breathe what we do, and we don't stop until the responsible party is held liable.

  • Leadership Is Trust.

    Our firm has been trusted to lead roles within some of the nation's largest litigations.

  • Knowledge Is Power.

    Our firm is focused on the science of the case and applying it to helping our clients recover.

Contact Us

We Focus On What You Need
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.